Abstract:The human myosin heavy chain superfamily comprises 12 different classes. Class 2 is the largest and is made up of 14 myosin heavy chain (MHC) genes (and 1 pseudogene). Class 2 myosin heavy chains form a dimer of two heavy chains, and associate with 2 pairs of light chains (essential and regulatory). Of the 13 types of class 2 myosins, 10 are expressed in striated muscle and the remaining 4 in non‐muscle cells and smooth muscle. All of the class 2 myosins form filaments. In striated muscle, the filaments contain precisely 294 molecules. In contrast, non‐muscle myosins form much shorter filaments (about 30 molecules). The activity of all of these myosins is regulated by an interaction of the heads (comprising the motor domain and lever) with the first part of the coiled coil (subfragment 2, S2) to form the so‐called ‘interacting heads’ motif. Non‐muscle and smooth muscle myosin heads are additionally regulated by an interaction of the head with the tail forming region (light meromyosin, LMM) to form a shutdown molecule. We use a combination of cell biology, and structural approaches, including electron microscopy to understand the effects of disease‐causing mutations in S2 and in LMM in class 2 myosins. Mutations in striated myosins (MyHCβ, MyHC2a) cause cardiac and skeletal muscle diseases respectively, although mutations in the distal LMM region of MyHCβ are predominantly associated with skeletal muscle disease. Mutations in non‐muscle myosin 2A (NM2A) cause a range of bleeding disorders. We determine how specific mutations affect the myosin's ability to form filaments and how they affect formation of its shutdown state. For example, we use circular dichroism to determine if specific mutations affect the secondary structure of LMM. We use negative stain electron microscopy to evaluate filament formation by the LMM (fused to GST, to prevent paracrystal formation) and we use GFP‐tagged MHC to evaluate the ability of each mutant to incorporate into filaments in cultured cells, myotubes and adult rat cardiomyocytes (Parker et al. (2018) J. Mol. Biol). We recently solved the structure of full‐length smooth muscle myosin (SMM) in its shutdown state (Scarff et al.. (2020) Nature) using CryoEM. This shows how the shutdown state is stabilised and enables us to predict how mutations might disrupt it. Together with additional structural studies, we are starting to understand how specific mutations affect myosin function, to gain a better understanding of the disease process. Support or Funding Information This research is supported by the Medical Research Council, MR/R009406/1 and MR/S023593/1 to MP.

Structure of the native myosin filament in the relaxed cardiac sarcomere

Cryo-EM structure of the human cardiac myosin filament

Atomic model of the human cardiac muscle myosin filament

Structure of the thin filament in native skeletal muscles reveals its interaction with nebulin and two distinct conformations of myosin

Thick Filament Protein Network, Functions, and Disease Association.

Cryo-electron tomography of intact cardiac muscle reveals myosin binding protein-C linking myosin and actin filaments

Cardiac muscle thin filament structures reveal calcium regulatory mechanism

Cryo-EM structures of cardiac muscle α-actin mutants M305L and A331P give insights into the structural mechanisms of hypertrophic cardiomyopathy

Troponin structural dynamics in the native cardiac thin filament revealed by cryo electron microscopy

Crystal structures of human cardiac beta-myosin II S2-Delta provide insight into the functional role of the S2 subfragment

Complex architecture of cardiac muscle thick filaments revealed

Structural dynamics of the intrinsically disordered linker region of cardiac troponin T

An integrated picture of the structural pathways controlling the heart performance

The Curious Role of Sarcomeric Proteins in Control of Diverse Processes in Cardiac Myocytes

Myosin: Structure, Function, Regulation and Disease

In vitro motility of native thin filaments from Drosophila indirect flight muscles reveals that the held-up 2 TnI mutation affects calcium activation

The Mechanisms of Thin Filament Assembly and Length Regulation in Muscles

Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics

The structure and regulation of human muscle α-actinin

Cryo Atomic Force Microscopy Of Smooth Muscle Myosin.

Structure Of The Mid-Region Of Tropomyosin: Bending And Binding Sites For Actin